Aberrant silencing of the endocrine peptide gene tachykinin-1 in gastric cancer

Biochemical and Biophysical Research Communications

Volumn 378, Issue 3, 2009, Pages 605-609

  David, Stefan ^a   Kan, Takatsugu ^a   Cheng, Yulan ^a   Agarwal, Rachana ^a   Jin, Zhe ^a   Mori, Yuriko ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastric cancer; Microsatellite instability; MSI H; Promoter methylation; Real time quantitative MSP; Substance P; Tachykinin

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MESSENGER RNA; PROTEIN TACHYKININ 1; TACHYKININ; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE SILENCING; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MALE; METHYLATION; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TISSUE DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HELICOBACTER PYLORI; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROTEIN PRECURSORS; STOMACH NEOPLASMS; TACHYKININS;

HELICOBACTER PYLORI;

EID: 57749188445     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.11.078     Document Type: Article

References (23)

1. Hamilton J.P., and Meltzer S.J. A review of the genomics of gastric cancer. Clin. Gastroenterol. Hepatol. 4 (2006) 416-425
2. Sato F., and Meltzer S.J. CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer 106 (2006) 483-493
3. Toyota M., Ahuja N., Suzuki H., Itoh F., Ohe-Toyota M., Imai K., Baylin S.B., and Issa J.P. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 59 (1999) 5438-5442
4. Severini C., Improta G., Falconieri-Erspamer G., Salvadori S., and Erspamer V. The tachykinin peptide family. Pharmacol. Rev. 54 (2002) 285-322
5. Mori Y., Cai K., Cheng Y., Wang S., Paun B., Hamilton J.P., Jin Z., Sato F., Berki A.T., Kan T., Ito T., Mantzur C., Abraham J.M., and Meltzer S.J. A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. Gastroenterology 131 (2006) 797-808
6. Jin Z., Olaru A., Yang J., Sato F., Cheng Y., Kan T., Mori Y., Mantzur C., Paun B., Hamilton J.P., Ito T., Wang S., David S., Agarwal R., Beer D.G., Abraham J.M., and Meltzer S.J. Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancer. Clin. Cancer Res. 13 (2008) 6293-6300
7. Boland C.R., Thibodeau S.N., Hamilton S.R., Sidransky D., Eshleman J.R., Burt R.W., Meltzer S.J., Rodriguez-Bigas M.A., Fodde R., Ranzani G.N., and Srivastava S. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58 (1998) 5248-5257
8. Mori Y., Sato F., Selaru F.M., Olaru A., Perry K., Kimos M.C., Tamura G., Matsubara N., Wang S., Xu Y., Yin J., Zou T.T., Leggett B., Young J., Nukiwa T., Stine O.C., Abraham J.M., Shibata D., and Meltzer S.J. Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers. Cancer Res. 62 (2002) 3641-3645
9. Issa J.P. CpG-island methylation in aging and cancer. Curr. Top. Microbiol. Immunol. 249 (2000) 101-118
10. Fleisher A.S., Esteller M., Wang S., Tamura G., Suzuki H., Yin J., Zou T.T., Abraham J.M., Kong D., Smolinski K.N., Shi Y.Q., Rhyu M.G., Powell S.M., James S.P., Wilson K.T., Herman J.G., and Meltzer S.J. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res. 59 (1999) 1090-1095
11. Yamamoto H., Perez-Piteira J., Yoshida T., Terada M., Itoh F., Imai K., and Perucho M. Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology 116 (1999) 1348-1357
12. An C., Choi I.S., Yao J.C., Worah S., Xie K., Mansfield P.F., Ajani J.A., Rashid A., Hamilton S.R., and Wu T.T. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin. Cancer Res. 11 (2005) 656-663
13. Leung W.K., Man E.P., Yu J., Go M.Y., To K.F., Yamaoka Y., Cheng V.Y., Ng E.K., and Sung J.J. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin. Cancer Res. 12 (2006) 3216-3221
14. Maekita T., Nakazawa K., Mihara M., Nakajima T., Yanaoka K., Iguchi M., Arii K., Kaneda A., Tsukamoto T., Tatematsu M., Tamura G., Saito D., Sugimura T., Ichinose M., and Ushijima T. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res. 12 (2006) 989-995
15. Akhtar M., Cheng Y., Magno R.M., Ashktorab H., Smoot D.T., Meltzer S.J., and Wilson K.T. Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells. Cancer Res. 61 (2001) 2399-2403
16. Perri F., Cotugno R., Piepoli A., Merla A., Quitadamo M., Gentile A., Pilotto A., Annese V., and Andriulli A. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am. J. Gastroenterol. 102 (2007) 1361-1371
17. Koon H.W., Zhao D., Na X., Moyer M.P., and Pothoulakis C. Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes. J. Biol. Chem. 279 (2004) 45519-45527
18. Lieb K., Fiebich B.L., Berger M., Bauer J., and Schulze-Osthoff K. The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J. Immunol. 159 (1997) 4952-4958
19. Esteban F., Munoz M., Gonzalez-Moles M.A., and Rosso M. A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage. Cancer Metastasis Rev. 25 (2006) 137-145
20. Flageole H., Senterman M., and Trudel J.L. Substance P increases in vitro lymphokine-activated-killer (LAK) cell cytotoxicity against fresh colorectal cancer cells. J. Surg. Res. 53 (1992) 445-449
21. Castro-Obregon S., Rao R.V., del Rio G., Chen S.F., Poksay K.S., Rabizadeh S., Vesce S., Zhang X.K., Swanson R.A., and Bredesen D.E. Alternative, nonapoptotic programmed cell death: mediation by arrestin 2, ERK2, and Nur77. J. Biol. Chem. 279 (2004) 17543-17553
22. Rameshwar P., and Gascon P. Induction of negative hematopoietic regulators by neurokinin-A in bone marrow stroma. Blood 88 (1996) 98-106
23. Schmassmann A., Waser B., Flogerzi B., and Reubi J.C. Expression of functional neurokinin-1 receptors in regenerative glands during gastric wound healing in rodents. Gastroenterology 126 (2004) 784-795